S.B. No. 21
Session Year 2017
 


AN ACT CONCERNING HEALTH INSURANCE COVERAGE OF ORALLY AND INTRAVENOUSLY ADMINISTERED MEDICATIONS.

To require health insurance policies that provide coverage for prescription drugs to provide coverage for intravenously administered drugs on a basis no less favorable than orally administered drugs.

Introduced by:
Insurance and Real Estate Committee

 New today  2-4 days old  5 days & older
  Add Notes via cookie to SB-21

Add Notes to SB-21

*NOTE: Add to My Bills and Add Notes are cookie-based functions. If device cookies are cleaned, this information will be lost.

*NOTE: Add to My Bills and Add Notes are cookie-based functions. Browser must accept cookies from cga.ct.gov to function. If browser cookies are cleaned, bills will be lost.

Bill History

 Date Action Taken
 3/10/2017Favorable Change of Reference, Senate to Committee on Appropriations
 3/10/2017(LCO)Reported Out of Legislative Commissioners' Office
 3/8/2017(LCO)Filed with Legislative Commissioners' Office
 3/7/2017(INS)Joint Favorable Change of Reference Appropriations
 3/1/2017Referred to Joint Committee on Insurance and Real Estate
 2/28/2017Drafted by Committee
 2/23/2017(INS)Vote to Draft
 2/2/2017Public Hearing 02/07
 1/19/2017(INS)Reserved for Subject Matter Public Hearing
 1/9/2017Referred to Joint Committee on Insurance and Real Estate

Co-sponsors of SB-21

NOTE: Please direct all inquiries regarding the status of bills to the Office of the House Clerk and/or Senate Clerks' Office.